Article Details
Retrieved on: 2022-01-18 21:50:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Bod Australia Limited (ASX: BOD) has been given authorisation in the UK to trial a cannabis-based medicine with long-COVID patients.
Article found on: hempgazette.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here